机构：[1]Department of Pharmaceutics, School of Pharmacy, Southwest Medical University, No. 3-5, Zhongshan Road, Jiangyang District, Luzhou, Sichuan 646000, P.R. China.[2]Department of Oncology, The Affiliated Hospital of Southwest Medical University, No. 25, Taiping Street, Luzhou, Sichuan 646000, P.R. China.[3]Institute of Chinese Medicine and Pharmaceutical Chemistry, Chongqing Academy of Chinese Materia Medica, No. 34, Nanshan Road, Nanshan Street, Nan'an District, Chongqing 400065, P.R. China.
This study was supported by the basic research fund of the Science
and Technology Department of Sichuan Province of China (nos.
2020YJ0336 and 2020YJ0373), the Joint Fund of Luzhou City and
Southwest Medical University (nos. 2017LZXNYD-T02 and
2019LZXNYDZ07), the Science and Technology Fund of Luzhou Science and Technology and Human Resources Bureau (no. 2019-SYF-
35), the Science and Technology Innovation Team from Jiucheng Science and Technology Talent Cultivation Plan in Luzhou City (no.
2019-1), the Scientific Research Foundation of the Education Department of Sichuan Province (nos. 17ZA0439 and 18ZB0646), and by a
research grant from the Traditional Chinese Medicine Administration in Sichuan Province (no. 2018QN069).
语种：
外文
PubmedID：
中科院(CAS)分区：
出版当年[2020]版：
大类|2 区医学
小类|2 区肿瘤学2 区医学：研究与实验
最新[2023]版：
大类|2 区医学
小类|2 区医学：研究与实验3 区肿瘤学
第一作者：
第一作者机构：[1]Department of Pharmaceutics, School of Pharmacy, Southwest Medical University, No. 3-5, Zhongshan Road, Jiangyang District, Luzhou, Sichuan 646000, P.R. China.
共同第一作者：
通讯作者：
通讯机构：[1]Department of Pharmaceutics, School of Pharmacy, Southwest Medical University, No. 3-5, Zhongshan Road, Jiangyang District, Luzhou, Sichuan 646000, P.R. China.[*1]Department of Pharmaceutics, School of Pharmacy,Southwest Medical University, No. 3-5, Zhongshan Road, Jiangyang District,Luzhou, Sichuan 646000, P.R. China.
推荐引用方式(GB/T 7714)：
Hou Yi,Pi Chao,Feng Xianhu,et al.Antitumor Activity In Vivo and Vitro of New Chiral Derivatives of Baicalin and Induced Apoptosis via the PI3K/Akt Signaling Pathway.[J].Molecular therapy oncolytics.2020,19:67-78.doi:10.1016/j.omto.2020.08.018.
APA：
Hou Yi,Pi Chao,Feng Xianhu,Wang Yuanyuan,Fu Shaozhi...&Wei Yumeng.(2020).Antitumor Activity In Vivo and Vitro of New Chiral Derivatives of Baicalin and Induced Apoptosis via the PI3K/Akt Signaling Pathway..Molecular therapy oncolytics,19,
MLA：
Hou Yi,et al."Antitumor Activity In Vivo and Vitro of New Chiral Derivatives of Baicalin and Induced Apoptosis via the PI3K/Akt Signaling Pathway.".Molecular therapy oncolytics 19.(2020):67-78
